Trump Order Spurs FDA to Speed Reviews of Psychedelic Therapies
Newsweek
—
FDA fast‑tracks three psychedelic drugs after Trump order speeding research on depression and PTSD treatments.
- U.S. FDA plans ultra-fast review of three psychedelic drugs following Trump directive CTV News —
- US FDA plans ultra-fast review of 3 psychedelic drugs after Trump directive South China Morning Post —
- FDA grants quick review for 3 psychedelic drug trials NBC News —
- FDA fast-tracks psychedelic drug research following Trump executive order CNBC —
- FDA plans fast review of 3 psychedelic drugs following Trump directive Boston Globe —